Innovation and Biomarkers in Cancer Drug Development (IBCD) 2015

  • Email
  • Help

Details

TitleInnovation and Biomarkers in Cancer Drug Development (IBCD) 2015
Date03/12/2015 - 04/12/2015
LocationSquare Brussels meeting centre, Belgium
SummaryInnovation and Biomarkers in Cancer Drug Development (IBCD) 2015 will shine a spotlight on multi-stakeholder approaches to cancer drug development with new cancer biomarkers in a scientific programme which will include input from regulators, industry, academia, patients and payers. Without a doubt, the combined efforts of the European Organisation for Research and Treatment of Cancer (EORTC), an academic research organisation, the US National Cancer Institute (NCI), a governmental institution, the European Medicines Agency (EMA), a regulatory agency, and the American Association for Cancer Research (AACR), a professional scientific association, ensure that a unique programme focusing on multi-stakeholder approaches to cancer drug development will emerge. A rich scientific programme for IBCD 2015 has been developed covering topics of interest to all cancer drug development stakeholders. Registration open until 12/11/2015.

All documents

Media Videos


Related information

 

Contact point:

conferences@eortc.be